Lovisa Sunesson is currently the Director of Business Development at Vesper Bio, specializing in oral therapies for Frontotemporal Dementia. Previously, Lovisa held roles such as Associate Director of Business Development at TFS, and Innovation Officer at The National Veterinary Institute, where they established innovation strategies. They earned a PhD from Lund University, focusing on neuroblastoma and ALS, and have contributed to various projects aimed at promoting life sciences and business development throughout their career. Lovisa has also served as a jury member for the University Startup World Cup and as a board member at Commentor AB.
This person is not in the org chart
This person is not in any teams
This person is not in any offices